Wang et al. have corroborated that, in oral cancer, RUNX2 advances the EMT phenotype and metastasis through its synergistic interactions with CXCR4, AKT, and FOXA2 [68]. Here, FOXA2 is linked to lip and oral cavity carcinoma.